Cargando…

Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy

Detalles Bibliográficos
Autores principales: Zhao, Zehao, Dong, Shutong, Sun, Tienan, Han, Kangning, Huang, Xin, Ma, Meishi, Yang, Shiwei, Zhou, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368236/
https://www.ncbi.nlm.nih.gov/pubmed/37496668
http://dx.doi.org/10.3389/fcvm.2023.1250733
_version_ 1785077469443784704
author Zhao, Zehao
Dong, Shutong
Sun, Tienan
Han, Kangning
Huang, Xin
Ma, Meishi
Yang, Shiwei
Zhou, Yujie
author_facet Zhao, Zehao
Dong, Shutong
Sun, Tienan
Han, Kangning
Huang, Xin
Ma, Meishi
Yang, Shiwei
Zhou, Yujie
author_sort Zhao, Zehao
collection PubMed
description
format Online
Article
Text
id pubmed-10368236
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103682362023-07-26 Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy Zhao, Zehao Dong, Shutong Sun, Tienan Han, Kangning Huang, Xin Ma, Meishi Yang, Shiwei Zhou, Yujie Front Cardiovasc Med Cardiovascular Medicine Frontiers Media S.A. 2023-07-11 /pmc/articles/PMC10368236/ /pubmed/37496668 http://dx.doi.org/10.3389/fcvm.2023.1250733 Text en © 2023 Zhao, Dong, Sun, Han, Huang, Ma, Yang and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Zhao, Zehao
Dong, Shutong
Sun, Tienan
Han, Kangning
Huang, Xin
Ma, Meishi
Yang, Shiwei
Zhou, Yujie
Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
title Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
title_full Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
title_fullStr Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
title_full_unstemmed Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
title_short Corrigendum: The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
title_sort corrigendum: the association between higher ffas and high residual platelet reactivity among cad patients receiving clopidogrel therapy
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368236/
https://www.ncbi.nlm.nih.gov/pubmed/37496668
http://dx.doi.org/10.3389/fcvm.2023.1250733
work_keys_str_mv AT zhaozehao corrigendumtheassociationbetweenhigherffasandhighresidualplateletreactivityamongcadpatientsreceivingclopidogreltherapy
AT dongshutong corrigendumtheassociationbetweenhigherffasandhighresidualplateletreactivityamongcadpatientsreceivingclopidogreltherapy
AT suntienan corrigendumtheassociationbetweenhigherffasandhighresidualplateletreactivityamongcadpatientsreceivingclopidogreltherapy
AT hankangning corrigendumtheassociationbetweenhigherffasandhighresidualplateletreactivityamongcadpatientsreceivingclopidogreltherapy
AT huangxin corrigendumtheassociationbetweenhigherffasandhighresidualplateletreactivityamongcadpatientsreceivingclopidogreltherapy
AT mameishi corrigendumtheassociationbetweenhigherffasandhighresidualplateletreactivityamongcadpatientsreceivingclopidogreltherapy
AT yangshiwei corrigendumtheassociationbetweenhigherffasandhighresidualplateletreactivityamongcadpatientsreceivingclopidogreltherapy
AT zhouyujie corrigendumtheassociationbetweenhigherffasandhighresidualplateletreactivityamongcadpatientsreceivingclopidogreltherapy